Haemophilus b Conjugate Vaccine (Systemic)

Proper Use of This Vaccine

Dosing - Haemophilus b conjugate vaccine is an haemophilus b vaccine that has been prepared by adding a diphtheria-, meningococcal-, or tetanus-related substance to it. If the vaccine was prepared using a diphtheria-related substance, it is called either HbOC or PRP-D. If the vaccine was prepared using a meningococcal-related substance, it is called PRP-OMP. If the vaccine was prepared using a tetanus-related substance, it is called PRP-T. All of these subtypes of haemophilus b conjugate vaccine work the same way , but may be given at different ages or times.

The dose of haemophilus b conjugate vaccine will be different for different patients. The following information includes only the average doses of haemophilus b conjugate vaccine.

• For prevention of Haemophilus influenzae type b infection:
  • For HbOC or PRP-T injection dosage form:
    • Adults and children 5 years of age and older - Use and dose must be determined by your doctor.
    • Infants 2 to 6 months of age at the first dose - Three doses, two months apart, then a booster dose at fifteen months of age. The doses are injected into a muscle.
    • Children 7 to 11 months of age at the first dose - Two doses, two months apart, then a booster dose at fifteen months of age. The doses are injected into a muscle.
    • Children 12 to 14 months of age at the first dose - One dose, then a booster dose at fifteen months of age. The doses are injected into a muscle.
    • Children 15 to 59 months of age at the first dose - One dose injected into a muscle.
  • For PRP-D injection dosage form:
    • Adults and children 5 years of age and older - Use and dose must be determined by your doctor.
    • Infants and children up to 15 months of age - Use is not recommended.
    • Children 15 to 59 months of age at the first dose - One dose injected into a muscle.
  • For PRP-OMP injection dosage form:
    • Adults and children 5 years of age and older - Use and dose must be determined by your doctor.
    • Infants 2 to 6 months of age at the first dose - Two doses, two months apart, then a booster dose at twelve months of age. The doses are injected into a muscle.
    • Children 7 to 11 months of age at the first dose - Two doses, two months apart, then a booster dose at fifteen months of age. The doses are injected into a muscle.
    • Children 12 to 14 months of age at the first dose - One dose, then a booster dose at fifteen months of age. The doses are injected into a muscle.
    • Children 15 to 59 months of age at the first dose - One dose injected into a muscle.